Pulmonology Department

Expert center in Pulmonary Rare Disease

description

For many years, the Departement of Pulmology has developed expertise in the areas of diffuse interstitial lung disease (ILD). ILD diseases may integrate a specific involvement of connective vascular disease (CVD) and especially during PR and scleroderma. More rarely they fit into the context of a primary or secondary Sjögren disease or PM/DPM. They also be related to a diffuse alveolar hemorrhage (DAH) associated with a polyangiitis. Our group is mainly involved in the description of the inaugural or lung dominant forms of CVD. We are involved in the ERS/ARS task force to define the concept of Interstitial Pneumonia with Auto-immue features (IPAF). We contributed to the description of the inaugural pulmonary forms of DPM/PM associated with anti-synthetase antibodies. We also differentiated acute and progressive forms, for which prognosis appears different. A therapeutic trial project with the group of Professor O Benveniste is in progress. Similarly, we contributed to dismantle the causes of DAH in particular the immunological forms. We proposed a clinical diagnostic score to differentiate during the first 24 hours to the immunological and non-immunological causes in attempt to early begin immunosuppressors in the former. 

​A large national prospective trial is ongoing to validate this score and to confirm its impact on treatment. We also studied pulmonary complication of drug given in CVD including methotrexate and retuximab and develop a expert program to diagnose drug induced pneumonitis (Pneumodoc®). Finally, we are international experts in the field of pulmonary MALT lymphomas. We hypothesized 3 initiator mechanisms, the first related to recurrent gene translocation, the second related to an auto-immune chronic stimulation of B cells and the third secondary to anti-infectious response to an hypothetic pathogen. This pathogen is under investigation within a collaborative project with the Institut Pasteur and the Intergroup Study the Lymphoma Association (LYSA).

Fields of interest

Interstitial lung disease associated connective disease, immune alveolar hemorrhage, drug induced pneumonitis, idiopathic interstitial lung disease, pulmonary granulomatous disease

Affiliations

https://www.transimmunom.org/Picture%20library/Logos/SU_h.jpg AP-HP logo https://www.transimmunom.org/Picture%20library/Logos/Tenon.png

CADRANEL
Jacques

Department/Faculty
Director

Contact info

Address: Service de Pneumologie, Hôpital Tenon, 4 rue de la Chine
City: Paris
Postal code: 75970
Telephone: +33 1 56 01 61 47/65 31
Fax: + 33 1 56 01 69 91
Email: jacques.cadranel@tnn.aphp.fr

Top Publications